{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T02:08:03Z","timestamp":1783649283228,"version":"3.55.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007338","name":"All-India Institute of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007338","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jpsychires.2024.03.048","type":"journal-article","created":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T17:27:15Z","timestamp":1711646835000},"page":"302-308","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Efficacy and safety of low-dose amisulpride versus olanzapine-fluoxetine combination in post-schizophrenic depression: A randomized controlled trial"],"prefix":"10.1016","volume":"173","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6559-280X","authenticated-orcid":false,"given":"Tathagata","family":"Biswas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biswa Ranjan","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4063-9178","authenticated-orcid":false,"given":"Rituparna","family":"Maiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanta Kumar","family":"Padhy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8837-299X","authenticated-orcid":false,"given":"Archana","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2024.03.048_bib1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00213-009-1521-8","article-title":"Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo","volume":"205","author":"Abbas","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.jpsychires.2024.03.048_bib2","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0920-9964(90)90005-R","article-title":"A depression rating scale for schizophrenics","volume":"3","author":"Addington","year":"1990","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpsychires.2024.03.048_bib3","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.schres.2013.12.014","article-title":"Reliability and validity of the calgary depression scale for schizophrenia (CDSS) in youth at clinical high risk for psychosis","volume":"153","author":"Addington","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpsychires.2024.03.048_bib4","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/00004850-200111000-00001","article-title":"Faster response on amisulpride 50 mg versus sertraline 50-100 mg in patients with dysthymia or double depression: a randomized, double-blind, parallel group study","volume":"16","author":"Amore","year":"2001","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2024.03.048_bib5","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1192\/bjp.177.6.516","article-title":"Cognitive approach to depression and suicidal thinking in psychosis. 1. Ontogeny of post-psychotic depression","volume":"177","author":"Birchwood","year":"2000","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2024.03.048_bib6","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2147\/NDT.S5819","article-title":"Olanzapine and fluoxetine combination therapy for treatment-resistant depression: review of efficacy, safety, and study design issues","volume":"5","author":"Bobo","year":"2009","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.jpsychires.2024.03.048_bib7","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.5694\/mja12.10516","article-title":"Schizophrenia and depression","volume":"199","author":"Bosanac","year":"2013","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.jpsychires.2024.03.048_bib8","first-page":"28","article-title":"The clinical global impressions scale","volume":"4","author":"Busner","year":"2007","journal-title":"Psychiatry (Edgmont)"},{"key":"10.1016\/j.jpsychires.2024.03.048_bib9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00004850-200201000-00004","article-title":"Efficacy and safety of amisulpride 50 mg versus paroxetine 20 mg in major depression: a randomized, double-blind, parallel group study","volume":"17","author":"Cassano","year":"2002","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2024.03.048_bib10","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.2165\/00003495-200161140-00014","article-title":"Amisulpride: a review of its use in the management of schizophrenia","volume":"61","author":"Curran","year":"2001","journal-title":"Drugs"},{"key":"10.1016\/j.jpsychires.2024.03.048_bib11","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.schres.2005.06.001","article-title":"Olanzapine versus risperidone in the treatment of post-psychotic depression in schizophrenic patients","volume":"78","author":"Dollfus","year":"2005","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.jpsychires.2024.03.048_bib12","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1177\/0269881103017002010","article-title":"Differential effect of quetiapine on depressive symptoms in patients with partially responsive schizophrenia","volume":"17","author":"Emsley","year":"2003","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2024.03.048_bib13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s40263-015-0308-1","article-title":"A systematic review and network meta-analysis to assess the relative efficacy of antipsychotics for the treatment of positive and negative symptoms in early-onset schizophrenia","volume":"30","author":"Harvey","year":"2016","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jpsychires.2024.03.048_bib14","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1080\/13651500310002986","article-title":"The use of the Simpson Angus Scale for the assessment of movement disorder: a training guide","volume":"7","author":"Hawley","year":"2009","journal-title":"Int. J. Psychiatr. Clin. Pract."},{"key":"10.1016\/j.jpsychires.2024.03.048_bib15","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1176\/appi.ajp.2016.15081035","article-title":"Efficacy and safety of antidepressants added to antipsychotics for schizophrenia: a systematic review and meta-analysis","volume":"173","author":"Helfer","year":"2016","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jpsychires.2024.03.048_bib16","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"issue":"Suppl. 4","key":"10.1016\/j.jpsychires.2024.03.048_bib17","first-page":"S1","article-title":"From pharmacological profiles to clinical outcomes","volume":"15","author":"Kerwin","year":"2000","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"12","key":"10.1016\/j.jpsychires.2024.03.048_bib18","article-title":"Second-generation antipsychotics for major depressive disorder and dysthymia","author":"Komossa","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jpsychires.2024.03.048_bib19","doi-asserted-by":"crossref","first-page":"933","DOI":"10.2165\/00023210-200418130-00007","article-title":"Amisulpride: a review of its use in the management of schizophrenia","volume":"18","author":"McKeage","year":"2004","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jpsychires.2024.03.048_bib20","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2024.03.048_bib21","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jad.2014.11.044","article-title":"BDNF as a biomarker for successful treatment of mood disorders: a systematic & quantitative meta-analysis","volume":"174","author":"Polyakova","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2024.03.048_bib22","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.2044-8260.1998.tb01384.x","article-title":"Loss, humiliation and entrapment as appraisals of schizophrenic illness: a prospective study of depressed and non-depressed patients","volume":"37","author":"Rooske","year":"1998","journal-title":"Br. J. Clin. Psychol."},{"key":"10.1016\/j.jpsychires.2024.03.048_bib23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/schbul\/17.1.75","article-title":"Diagnosis of secondary depression in schizophrenia: implications for DSM-IV","volume":"17","author":"Siris","year":"1991","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.jpsychires.2024.03.048_bib24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0920-9964(88)90037-0","article-title":"Fluphenazine decanoate dose and severity of depression in patients with post-psychotic depression","volume":"1","author":"Siris","year":"1988","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.jpsychires.2024.03.048_bib25","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1600-0447.2009.01506.x","article-title":"The evolution of depression and suicidality in first episode psychosis","volume":"122","author":"Upthegrove","year":"2010","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jpsychires.2024.03.048_bib26","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1001\/archpsyc.1978.01770330075006","article-title":"\u201cAkinetic depression\u201d in schizophrenia","volume":"35","author":"Van Putten","year":"1978","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.jpsychires.2024.03.048_bib27","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/hipo.20156","article-title":"Hippocampal neurogenesis: opposing effects of stress and antidepressant treatment","volume":"16","author":"Warner-Schmidt","year":"2006","journal-title":"Hippocampus"},{"key":"10.1016\/j.jpsychires.2024.03.048_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002305","article-title":"Antidepressants for people with both schizophrenia and depression","author":"Whitehead","year":"2002","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jpsychires.2024.03.048_bib29","series-title":"The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research","year":"1993"},{"key":"10.1016\/j.jpsychires.2024.03.048_bib30","first-page":"1508","article-title":"Decreased serum BDNF levels in chronic institutionalized schizophrenia on long-term treatment with typical and atypical antipsychotics. Progress in Neuro-Psychopharmacology and Biological Psychiatry, Bed nucleus of the stria terminalis: anatomy","volume":"33","author":"Xiu","year":"2009","journal-title":"physiology, functions"},{"key":"10.1016\/j.jpsychires.2024.03.048_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/hup.2801","article-title":"Efficacy of amisulpride for depressive symptoms in individuals with mental disorders: a systematic review and meta-analysis","volume":"36","author":"Zangani","year":"2021","journal-title":"Hum. Psychopharmacol."}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395624001900?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395624001900?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T19:45:24Z","timestamp":1713296724000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395624001900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":31,"alternative-id":["S0022395624001900"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2024.03.048","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of low-dose amisulpride versus olanzapine-fluoxetine combination in post-schizophrenic depression: A randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2024.03.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}